Efficacy and Safety of Dapagliflozin for the Hospital Management of Patients With Type 2 Diabetes
Clinical trial NCT05457933 · COMPLETED
Trial details
- NCT number
- NCT05457933
- Sponsor
- Medanta, The Medicity, India
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-29
- Primary completion
- 2023-01-14
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.